BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Meridian Co. Ltd. (MRDAF) Signs Letter of Intent for Private Placement Funding


3/31/2010 10:33:04 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 31, 2010) - Meridian Co., Ltd. (OTCBB: MRDAF), a company engaged in the research, development, manufacturing, and sales of advanced medical devices, announces that it has signed a Letter of Intent (LOI) with a Shareholder Investment Group of current shareholders seeking to make certain board changes and to assist with financing, whereby the Shareholder Group will arrange for private placement financing of Meridian Co. and certain nominees of the Shareholder Group will be appointed to the board of directors of Meridian Co., Ltd.

Details of the financing include the company's willingness to enter into an agreement to make significant changes to its board if funding requirements are met. The Shareholder Investment Group will use its best efforts to arrange this financing by the deadlines set out in the LOI. The initial private placement funding will be in the amount up to $1,000,000.00usd, with the opportunity for additional private placement financing up to $4,000,000.00usd within six months of this letter of agreement.

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the company.


Contacts:
Meridian Co., Ltd.
Peter Holeczek and/or Anna Brazier
Corporate Communications
604-688-2448
www.meridian.co.kr/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES